Otago glaucoma surgery outcome study: Cytology and immunohistochemical staining of bleb capsules around Molteno implants

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 5, 2006, Pages 1975-1981

  Molteno, Anthony C B ^a   Suter, Antony J ^b   Fenwick, Mark ^c   Bevin, Tui H ^a   Dempster, Alex G ^d  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b DUNEDIN HOSPITAL   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d Southern Community Laboratories   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN FIBER; CASP3 PROTEIN, HUMAN; CASPASE; CASPASE 3; CD68 ANTIGEN, HUMAN; CYCLINE; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ADULT; AGED; APOPTOSIS; ARTICLE; CAPILLARY; CELL ACTIVATION; CELL LABELING; CELL PROLIFERATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CLINICAL FEATURE; CONJUNCTIVA; CONNECTIVE TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPATHOLOGY; ENUCLEATION; EXTRACELLULAR MATRIX; GLAUCOMA; GLAUCOMA DRAINAGE IMPLANT; GLAUCOMA SURGERY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAOCULAR PRESSURE; MEMBRANE VESICLE; METABOLIC ACTIVATION; MICROSCOPY; MITOSIS; OUTCOME ASSESSMENT; PHAGOCYTOSIS; PRIORITY JOURNAL; BLISTER; CELL COUNT; ENZYME IMMUNOASSAY; FIBROBLAST; MACROPHAGE; MEMBRANE; METABOLISM; MIDDLE AGED; NICK END LABELING; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; APOPTOSIS; BLISTER; CASPASE 3; CASPASES; CELL COUNT; CELL PROLIFERATION; CONJUNCTIVA; CONNECTIVE TISSUE; FIBROBLASTS; GLAUCOMA; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; MACROPHAGES; MEMBRANES; MIDDLE AGED; MOLTENO IMPLANTS; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 33744759559     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0988     Document Type: Article

References (25)

1. Molteno ACB, Fucik M, Dempster AG, Bevin TH. Otago Glaucoma Surgery Outcome Study. Factors controlling capsule fibrosis around Molteno implants with histopathological correlation. Ophthalmology. 2003;110:2198-2206.
2. Rubin B, Chan C-C, Burnier M, et al. Histopathologic study of the Molteno glaucoma implant in three patients. Am J Ophthalmol. 1990;110:371-379.
3. Classen L, Kivelä T, Tarkkanen A. Histopathologic and immunohistochemical analysis of the filtration bleb after unsuccessful glaucoma seton implantation. Am J Ophthalmol. 1996;122:205-212.
4. Molteno ACB, Ancker E, Van Biljon G. Surgical technique for advanced juvenile glaucoma. Arch Ophthalmol. 1984;102:51-57.
5. Molteno ACB, Straughan JL, Ancker E. Control of bleb fibrosis after glaucoma surgery by anti-inflammatory agents. S Afr Med J. 1976;50:881-885.
6. Molteno ACB, Dempster AG. Methods of controlling bleb fibrosis around draining implants. In: Glaucoma. Proceedings of the Fourth International Symposium of the Northern Eye Institute. Manchester, UK, July, 14-16, 1988; London: Pergamon Press; 192-211.
7. Vote B, Fuller JR, Bevin TH, Molteno ACB. Systemic anti-inflammatory fibrosis suppression in threatened trabeculectomy failure. Clin Exp Ophthalmol. 2004;32:81-86.
8. Molteno ACB, Van Biljon G, Ancker E. Two-stage insertion of glaucoma drainage implants. Trans Ophthalmol Soc NZ. 1979;3117-3126.
9. Molteno ACB, Polkinghorne PJ, Bowbyes JA. The vicryl tie technique for inserting a draining implant in the treatment of secondary glaucoma. Aust NZ J Ophthalmol. 1986;14:343-354.
10. MacSween RNM, Whaley K. Muir's Textbook of Pathology. 13th ed. London: Edward Arnold; 1992.
11. Molteno ACB. New implant for drainage in glaucoma: clinical trial. Br J Ophthalmol. 1969;53:606-615.
12. Molteno ACB, Straughan JL, Ancker E. Long tube implants in the management of glaucoma. S Afr Med J. 1976;50:1062-1066.
13. Molteno ACB. A new implant for glaucoma: effect of removing implants. Br J Ophthalmol. 1971;55:28-37.
14. Falini B, Flenghi L, Pileri S, et al. PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol. 1993;142:1359-1372.
15. Paunesku T, Mittal S, Protic M, et al. Proliferating cell nuclear antigen (PCNA): ringmaster of the genome. Int J Radiat Biol. 2001;77:1007-1021.
16. Valavanis C, Hu Y, Yang Y, et al. Modern cell lines for the study of apoptosis in vitro. Methods Cell Biol. 2001;66:418-437.
17. Lecoeur H. Nuclear apoptosis detection by flow cytometry: influence of endogenous endonucleases. Exp Cell Res. 2002;277:1-14.
18. Huppertz B, Frank HG, Kaufmann P. The apoptosis cascade: morphological and immunohistochemical methods for its visualisation. Anat Embryol. 1999;200:1-18.
19. Fenwick MA, Hurst PR. Immunohistochemical localization of active caspase-3 in the mouse ovary: growth and atresia of small follicles. Reproduction. 2002;124:659-665.
20. Bloom W, Fawcett DW. A Textbook of Histology. 10th ed. Philadelphia: WB Saunders; 1975.
21. Duke-Elder S, Gloster J. The physiology of the eye. In: Duke-Elder S, ed. System of Ophthalmology. Vol. 4. London: Henry Kimpton; 1968:3-432.
22. Ogasawara J, Watanabe-Fukunaga R, Adachi M, et al. Lethal effect of the anti-Fas antibody in mice. Nature. 1993;364:806-809.
23. Willmer EN. Cytology and Evolution. New York: Academic Press; 1960.
24. Sugar HS. The glaucomas. In: Sorsby A, ed. Modern Ophthalmology. Vol 4. London: Butterworths; 1964:531-97.
25. Nagata A. Apoptosis by death factor. Cell. 1997;88:355-365.